Packaging Size | 1x10 |
Packaging Type | tablet |
Dose/Strength (ex. 1 mg or 1 ml) | 1 mg |
Usage | Clinical, Hospital |
Brand Name | Entavir |
Generic Name | Entecavir |
Company | Cipla |
Strength | 1mg |
Packing | 1X10 |
Type | Tablet |
Additional Information:
Packaging Size | 1x10 |
Packaging Type | tablet |
Dose/Strength (ex. 1 mg or 1 ml) | 0.5 mg |
Usage | Hospital |
Brand Name | Entavir |
Generic Name | Entecavir |
Company | Cipla |
Strength | 0.5 mg |
Packing | 1X10 |
Type | Tablet |
Additional Information:
Dose/Strength (mg or ml) | 400 mg |
Pack Size | 1x28 |
Pack Type | tablet |
Brand Name | Hepcinat |
Generic Name | Sofosbuvir |
Company | Natco |
Strength | 400mg |
packing | 1X28 |
Type | Tablet |
Additional Information:
Packaging Size | 1x30 |
Packaging Type | tablet |
Dose/Strength (ex. 1 mg or 1 ml) | 10 mg |
Usage | Clinical, Hospital |
Brand Name | Adesera 10 MG |
Generic Name | Adefovir dipivoxil 10 MG |
Company | CIPLA |
Strength | 10 MG |
packing | 1X30 |
Type | Tablets |
Additional Information:
Strength/Dose (in mg or ml) | 400 mg |
Pack Size | 1x28 |
Product Type | Finish Product |
Brand Preference | zydus |
Uses:
SoviHep 400mg (Sofosbuvir) is a nucleotide analog inhibitor of hepatitis C virus NS5B polymerase—the key enzyme mediating HCV RNA replication. Sofosbuvir is a prodrug and after ingestion it is rapidly converted to GS-331007, the predominant circulating drug that accounts for greater than 90% of the systemically active drug. This triphosphate compound mimics the natural cellular uridine nucleotide and is incorporated by the HCV RNA polymerase into the elongating RNA primer strand, resulting in chain termination. The active form GS-461203 targets the NS5B catalytic site and acts as a non-obligate chain terminator. The active compound (GS-461203) does not inhibit host DNA polymerases, RNA polymerases, or mitochondrial RNA polymerase.SoviHep 400mg is available as a 400 mg tablet. The recommended dose of sofosbuvir is 400 mg taken orally once daily, with or without food. The 400 mg dose of sofosbuvir should be used, regardless of the patient's genotype and prior hepatitis C treatment experience. No dose adjustment is needed for mild-to-moderate renal impairment or with mild, moderate, or severe hepatic impairment. SoviHep 400mg has been very well-tolerated in clinical trial. The most common adverse effects observed with sofosbuvir, when used in combination with ribavirin, have been fatigue and headache. Sofosbuvir is pregnancy category B.The major concern with drug interactions exists with medications that are strong inducers of intestinal P-gp, such as rifampin and St. John's wort, since these compounds may significantly lower sofosbuvir and GS-331007 levels. The coadministration of sofosbuvir with the following medications is not recommended because these medications may significantly lower sofosbuvir levels:
Brand Name: | SoviHep |
Generic Name: | Sofosbuvir |
Company: | Zydus Cadila |
Strength: | 400mg |
Packing: | 1X28 |
Type: | Tablet |
Strength/Dose (in mg or ml) | 400 mg |
Pack Size | 1x28 |
Product Type | Finish Product |
Brand Name: | Sofovir |
Generic Name: | Sofosbuvir |
Company: | Hetero Drugs |
Strength: | 400mg |
Packing: | 1X28 |
Type: | Tablet |
Brand Name: | Sofocure |
Generic Name: | Sofosbuvir |
Company: | Emcure |
Strength: | 400mg |
Packing: | 1x28 |
Type: | Tablet |
Use: | ---- |
Packaging Size | 1 vial |
Packaging Type | injection |
Dose/Strength (ex. 1 mg or 1 ml) | 180 mcg/0.5ml |
Usage | Clinical, Hospital |
Peginterferon alfa-2a is used to treat chronic hepatitis B or C.
Peginterferon alfa-2a is often used together with another medication called ribavirin
Specification:Brand Name: | Exxura |
Generic Name: | Peginterferon alpha 2a |
Company: | Roche |
Strength: | 180mcg/0.5ml |
Packing: | 1 |
Type: | Injection |
Uses: | ---- |
Packaging Size | 1 vial |
Packaging Type | injection |
Dose/Strength (ex. 1 mg or 1 ml) | 3MIU/0.5ml s.c. |
Usage | Clinical, Hospital |
Brand Name: | Roferon A |
Generic Name: | Roferon A |
Company: | Roche |
Strength: | 3MIU/0.5ml s.c. |
packing: | Vail |
Type: | Injection |
Uses: | Hepatitis Treatment Drugs |
Strength/Dose (in mg or ml) | 400 mg |
Pack Size | 1x28 |
Product Type | Finish Product |
Brand Preference | DR RIDDY`S |
Uses:
Resof contains Sofosbuvir.
Sofosbuvir is used for Treating chronic hepatitis C virus (HCV) infection in certain patients. It must be used with ribavirin or in combination with peginterferon alfa and ribavirin.
Sofosbuvir is an HCV nucleotide analog polymerase inhibitor. It reduces the amount of HCV in the body by preventing the spread of the HCV within the body.
Brand Name: | Resof |
Generic Name: | Sofosbuvir |
Company: | Dr. Reddyi's |
Strength: | 400mg |
packing: | 1X28 |
Type: | Tablet |
Uses: | Hepatitis C |
Dose/Strength (mg or ml) | 400 mg |
Pack Size | 1x28` |
Pack Type | tablet |
Brand Name: | Hepcinat-LP |
Generic Name: | Sofosbuvir |
Company: | Nacto |
Strength: | 400mg |
Packing: | 1x28 |
Type: | Tablet |
Uses: | Hepatitis C |
Showcase Gallery
© Leehpl Ventures Pvt. Ltd.. All Rights Reserved (Terms of Use)
Developed and Managed by IndiaMART InterMESH Limited